Winning Health(SZ:300253)2025-01-23 09:16Financial Performance - The company's net profit attributable to shareholders is expected to be between 80 million RMB and 120 million RMB, representing a decline of 66.48% to 77.65% compared to the same period last year, which was 357.96 million RMB[2] - The net profit after deducting non-recurring losses is projected to be between 109.5 million RMB and 149.5 million RMB, reflecting a decrease of 55.05% to 67.07% year-on-year, compared to 332.57 million RMB last year[2] - Non-recurring gains and losses are expected to negatively impact net profit by about 29.5 million RMB, compared to a positive impact of 25.39 million RMB in the previous year[5] Goodwill and Impairment - The company plans to recognize goodwill impairment of approximately 67 million RMB, a significant increase from 6.6 million RMB in the same period last year[5] Operational Challenges - The company has experienced a decline in operating revenue due to factors such as deferred customer demand and delays in project delivery, while focusing on improving operational quality[4] Cost Management - The company has implemented cost reduction and efficiency enhancement measures, resulting in a year-on-year decrease in total labor costs and expenses[4] Accounts Receivable Management - The management has increased efforts in accounts receivable management, leading to continuous growth in sales collections[4] Financial Reporting - The financial data in the earnings forecast has not been audited by registered accountants, and the final figures will be disclosed in the 2024 annual report[6]